# French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

> **NCT06287723** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Cancer
- Liver Metastases
- Stage IV Colorectal Cancer
- Minimal Residual Disease
- Liquid Biopsy
- ctDNA

## Interventions

- **BIOLOGICAL:** Blood sample/Liquid biopsy

## Key facts

- **NCT ID:** NCT06287723
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06287723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06287723, "French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06287723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*